Back to News
Market Impact: 0.28
Centene Reaffirms 2026 EPS Outlook as Medicaid Membership Decline Deepens
Source: marketbeat.com
Corporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Centene reaffirmed its 2026 adjusted diluted EPS guidance of more than $4.80. CEO Sarah London said performance during the first two months of the third quarter was in line with expectations, signaling no deterioration in the company’s outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.22
Ticker Sentiment
CNC0.42
More News
- All eyes on PTC earnings amid pending Schneider acquisition
- Jefferies downgrades Haleon stock rating on margin concerns
- Dow Jones Forecast: Futures Surge as Democrats Take Congress, AI Stocks Lag
- Which sectors will benefit most and face pressure after Democratic sweep?
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh